The US Department of Health and Human Services (HHS), through its Administration for Strategic Preparedness and Response (ASPR), is conducting a comprehensive assessment of the US pharmaceutical key starting materials (KSMs) industrial base to “identify supply chain vulnerabilities and inform strategies to strengthen domestic manufacturing capabilities.”
In partnership with the